Aveanna Healthcare (AVAH) Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVAH, but not buy additional shares or sell existing shares.
View AVAH analyst ratings or view top-rated stocks.

8 equities research analysts have issued 12 month price objectives for Aveanna Healthcare's stock. Their AVAH share price forecasts range from $1.00 to $5.00. On average, they predict the company's share price to reach $2.34 in the next twelve months. This suggests a possible upside of 79.0% from the stock's current price.
View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts.

Aveanna Healthcare's stock was trading at $0.78 at the start of the year. Since then, AVAH stock has increased by 67.9% and is now trading at $1.31.
View the best growth stocks for 2023 here.

Aveanna Healthcare saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,920,000 shares, an increase of 33.9% from the April 30th total of 2,180,000 shares. Based on an average daily volume of 454,100 shares, the days-to-cover ratio is currently 6.4 days. Approximately 6.0% of the shares of the stock are sold short.
View Aveanna Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our AVAH earnings forecast.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) released its quarterly earnings data on Thursday, March, 16th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.02. The company earned $451.15 million during the quarter, compared to the consensus estimate of $448.17 million. Aveanna Healthcare had a negative net margin of 39.89% and a negative trailing twelve-month return on equity of 19.78%.

Invesco Raymond James SB-1 Equity ETF holds 331,073 shares of AVAH stock, representing 0.35% of its portfolio.

Aveanna Healthcare updated its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.84B-, compared to the consensus revenue estimate of $1.85 billion.

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH."

Aveanna Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Principal Financial Group Inc. (1.70%), BlackRock Inc. (1.60%), Putnam Investments LLC (0.61%), Geode Capital Management LLC (0.52%), State Street Corp (0.44%) and Barclays PLC (0.04%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi.
View institutional ownership trends.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AVAH stock can currently be purchased for approximately $1.31.

Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $247.41 million and generates $1.79 billion in revenue each year. The company earns $-662,030,000.00 in net income (profit) each year or ($3.88) on an earnings per share basis.

The company employs 3,700 workers across the globe.

Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com.